Quintela, Marcos http://orcid.org/0000-0002-9628-695X
James, David W.
Garcia, Jetzabel
Edwards, Kadie http://orcid.org/0000-0002-1359-0359
Margarit, Lavinia
Das, Nagindra
Lutchman-Singh, Kerryn
Beynon, Amy L.
Rioja, Inmaculada
Prinjha, Rab K.
Harker, Nicola R.
Gonzalez, Deyarina
Steven Conlan, R. http://orcid.org/0000-0002-2562-3461
Francis, Lewis W. http://orcid.org/0000-0002-7803-7714
Funding for this research was provided by:
Welsh Government and European Development Fund
Article History
Received: 17 October 2022
Revised: 29 March 2023
Accepted: 6 April 2023
First Online: 29 April 2023
Competing interests
: RKP and NRH are employees and shareholders of GlaxosSmithKline. IR was an employee and shareholder of GlaxoSmithKline when the study was carried out. The remaining authors declare no competing interests.
: Ethical approval for processing ovarian patient samples has been obtained through Local Research Ethics Committee LREC Wales (ref 15/wa/0065) for the collection of biopsies from consented patients. Formal written consent was obtained from all patients at the time of recruitment into the study. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.